During the 61 stAmerican Society of Hematology (ASH) meeting in Orlando, US, the Lymphoma Hub were pleased to speak to Martin Dreyling, University of Munich, Munich, DE. Martin Dreyling provides an overview of the practice-changing abstracts in mantle cell lymphoma from ASH 2019.
Martin Dreyling talks about treatment strategies for mantle cell lymphoma (MCL). He explains MCL has been subcategorized to conventional indolent type and aggressive MCL, with each receiving a different treatment approach. He also discusses studies that focus on the treatment of MCL in the relapsed setting.